Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2025-12-26 @ 2:05 AM
Study NCT ID:
NCT05697705
Status:
COMPLETED
Last Update Posted:
2024-11-21
First Post:
2023-01-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-18
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-23
First Submit QC Date:
None
Study First Post Date:
2023-01-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2024-11-21
Last Update Post Date Type:
ACTUAL